RPID vs. DTIL, HBIO, SEER, AKYA, BNGO, PRE, OMIC, AXDX, TLIS, and ASTC
Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Precision BioSciences (DTIL), Harvard Bioscience (HBIO), Seer (SEER), Akoya Biosciences (AKYA), Bionano Genomics (BNGO), Prenetics Global (PRE), Singular Genomics Systems (OMIC), Accelerate Diagnostics (AXDX), Talis Biomedical (TLIS), and Astrotech (ASTC).
Precision BioSciences (NASDAQ:DTIL) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment, dividends and community ranking.
Precision BioSciences has a beta of 1.62, suggesting that its stock price is 62% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.
Precision BioSciences received 85 more outperform votes than Rapid Micro Biosystems when rated by MarketBeat users. Likewise, 67.42% of users gave Precision BioSciences an outperform vote while only 26.67% of users gave Rapid Micro Biosystems an outperform vote.
38.0% of Precision BioSciences shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 4.0% of Precision BioSciences shares are owned by insiders. Comparatively, 30.4% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Rapid Micro Biosystems has lower revenue, but higher earnings than Precision BioSciences. Precision BioSciences is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.
Precision BioSciences has a net margin of -48.10% compared to Precision BioSciences' net margin of -224.73%. Precision BioSciences' return on equity of -42.25% beat Rapid Micro Biosystems' return on equity.
Precision BioSciences presently has a consensus price target of $46.33, indicating a potential upside of 259.17%. Given Rapid Micro Biosystems' higher possible upside, equities analysts clearly believe Precision BioSciences is more favorable than Rapid Micro Biosystems.
In the previous week, Precision BioSciences had 5 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 7 mentions for Precision BioSciences and 2 mentions for Rapid Micro Biosystems. Precision BioSciences' average media sentiment score of 1.44 beat Rapid Micro Biosystems' score of 0.71 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.
Summary
Precision BioSciences beats Rapid Micro Biosystems on 10 of the 17 factors compared between the two stocks.
Get Rapid Micro Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Rapid Micro Biosystems Competitors List
Related Companies and Tools
